BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19733696)

  • 1. Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance.
    Sun Y; Cai TT; Shen Y; Zhou XB; Chen T; Xu Q
    Int Immunopharmacol; 2009 Nov; 9(12):1437-43. PubMed ID: 19733696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.
    Singer M; Trugnan G; Chelbi-Alix MK
    Innate Immun; 2011 Aug; 17(4):365-74. PubMed ID: 20693187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The water-soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia (Designated as MAK) ameliorates murine colitis induced by trinitrobenzene sulphonic acid.
    Hanaoka R; Ueno Y; Tanaka S; Nagai K; Onitake T; Yoshioka K; Chayama K
    Scand J Immunol; 2011 Nov; 74(5):454-62. PubMed ID: 21973321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fumigaclavine C, an fungal metabolite, improves experimental colitis in mice via downregulating Th1 cytokine production and matrix metalloproteinase activity.
    Wu XF; Fei MJ; Shu RG; Tan RX; Xu Q
    Int Immunopharmacol; 2005 Sep; 5(10):1543-53. PubMed ID: 16023606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sinomenine attenuates 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice.
    Cheng H; Xia B; Guo Q; Zhang L; Wang F; Jiang L; Wang Z; Zhang Y; Li C
    Int Immunopharmacol; 2007 May; 7(5):604-11. PubMed ID: 17386408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide treatment reduces colon injury induced by experimental colitis.
    Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
    Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions.
    Liu BG; Jia XM; Cao YY; Chen SH; Gao PH; Wang Y; Jiang YY; Cao YB
    J Ethnopharmacol; 2008 Jan; 115(1):1-8. PubMed ID: 17964746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of taurohyodeoxycholic acid from Pulvis Fellis Suis on trinitrobenzene sulfonic acid induced ulcerative colitis in mice.
    He J; Liang J; Zhu S; Zhao W; Zhang Y; Sun W
    Eur J Pharmacol; 2011 Nov; 670(1):229-35. PubMed ID: 21925164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
    Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
    Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis.
    Zhang M; Deng CS; Zheng JJ; Xia J
    Acta Pharmacol Sin; 2006 Aug; 27(8):1071-7. PubMed ID: 16867261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
    Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
    Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible mechanisms of Fructus Mume pill in the treatment of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats.
    Liu L; Yuan S; Sun Y; Long Y; Li Y; Niu Y; Li C; Gan H; Cao S; Mei Q
    J Ethnopharmacol; 2009 Dec; 126(3):557-64. PubMed ID: 19703546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Suppression of Schistosoma japonicum eggs on TNBS-induced colitis in mice].
    Mo HM; Liu WQ; Lei JH; Cheng YL; Wang CZ; Li YL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Oct; 25(5):381-4. PubMed ID: 18441989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
    Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
    Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beneficial effect of Rheum tanguticum polysaccharide on protecting against diarrhea, colonic inflammation and ulceration in rats with TNBS-induced colitis: the role of macrophage mannose receptor in inflammation and immune response.
    Liu L; Guo Z; Lv Z; Sun Y; Cao W; Zhang R; Liu Z; Li C; Cao S; Mei Q
    Int Immunopharmacol; 2008 Nov; 8(11):1481-92. PubMed ID: 18790466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
    Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.